Plant – Page 3 – Talk Bio

FDA Approves Over-the-Counter Hearing Aid Software for Apple AirPods Pro

12 months ago talkbio0Tagged Approved, Computer software, Genus Malus, Hearing, Hearing Aids, Moderate (severity modifier), United States Food and Drug Administration

FDA approval, over-the-counter hearing aids, Apple AirPods Pro, hearing aid software, mild to moderate hearing loss

UCB Divests Chinese Production Plant and Older Medications for $680 Million

1 year ago talkbio0Tagged China, Drug Industry, older medications, Plants, production, UCB

UCB, production plant, older medications, China, $680M, pharmaceutical industry, divestment

Eisai Partners with SEED Therapeutics for $1.5 Billion Biobucks Deal in Neurodegeneration and Oncology

1 year ago talkbio0Tagged biobucks, Eisai, molecular glue degraders, Neoplasms, Nerve Degeneration, Plant seeds

Eisai, SEED Therapeutics, biobucks deal, neurodegeneration, oncology, molecular glue degraders

Biopharma Layoff Tracker 2024: uniQure, Vir, Arbutus, and More Cut Staff

1 year ago talkbio0Tagged Arbutus, Biopharma layoffs, Industry, UniQure, Vir

biopharma layoffs, uniQure, Vir, Arbutus, biotech industry, job cuts, restructuring initiatives

Montara Therapeutics Launches with $8M to Develop Safer Neurological Therapeutics

1 year ago talkbio0Tagged BrainOnly, Montara Therapeutics, Neurologic (qualifier value), Plant seeds, safer

Montara Therapeutics, neurological therapeutics, BrainOnly platform, seed funding, safer treatments

President Biden Highlights Achievements in Lowering Prescription Drug Costs as He Steps Down from Re-election Campaign

1 year ago talkbio0Tagged Bidens, campaign, Drug Industry, Economic Inflation, Health Care Costs, Medicare, Prescription procedure, President brand of dental material, re-election

President Biden, drug pricing, re-election campaign, Medicare, Inflation Reduction Act, prescription drug costs, health care costs, pharmaceutical industry

Cardurion Pharmaceuticals Raises $260M in Series B Funding to Challenge Statin-Dominated Cardiovascular Market

1 year ago talkbio0Tagged Administration occupational activities, Ascenta Capital, biotech, Blue color, Capital, Capital Management, Cardiovascular system, Cardurion, Farallon, fidelity, Genus: Digitalis, Granulovirus, Healthcare Opportunities, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Invus, Millennium, NEA, Research Company, Series B

Cardurion Pharmaceuticals, Series B Funding, Cardiovascular, Statins, Biotech, Bain Capital, Ascenta Capital, NEA, GV, Fidelity Management & Research Company, Millennium Management, Farallon Capital Management, Invus, Blue Owl Healthcare Opportunities, Delos Capital, Digitalis Ventures